Moxisylyte

Moxisylyte
Systematic (IUPAC) name
4-[2-(Dimethylamino)ethoxy]-5-isopropyl-2-methylphenyl acetate
Clinical data
AHFS/Drugs.com International Drug Names
Identifiers
CAS Number 54-32-0 YesY
ATC code G04BE06 (WHO) C04AX10
PubChem CID 4260
ChemSpider 4110
UNII PW8QYA7KI0 YesY
KEGG D08239 YesY
Chemical data
Formula C16H25NO3
Molar mass 279.375 g/mol
  (verify)

Moxisylyte, also known as thymoxamine, is a drug used in urology for the treatment of erectile dysfunction.[1] It is an α1-adrenergic antagonist.[2]

References

  1. British National Formulary 69, Chapter2.6.4, page 142
  2. Sakakibara R, Hattori T, Uchiyama T, et al. (March 2000). "Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte". J. Auton. Nerv. Syst. 79 (2–3): 191–5. doi:10.1016/S0165-1838(99)00105-8. PMID 10699651.



This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.